Viatris
Audrey Everly currently serves as the Director of Global Regulatory Affairs CMC Strategy at Viatris since November 2023. Prior to this role, experience at Pfizer spanned nearly 28 years, with positions including Regional Regulatory HUB Strategist Hospital Lead for Africa, the Middle East, and Latin America; Director of Post Approval CMC; and Sr. Manager of Global Manufacturing Compliance, where validation support for manufacturing sites was provided. Additional roles included Quality Assurance Specialist/Supervisor, Quality Engineer, and Senior Microbiologist, focusing on compliance, technical guidance, and quality assurance in pharmaceutical manufacturing. Audrey's career began at Wyeth Pharmaceuticals as a QA Analyst. Educational qualifications include an MBA in Pharmaceutical Studies from Fairleigh Dickinson University and a BS in Environmental Science from East Stroudsburg University of Pennsylvania.
This person is not in any teams
This person is not in any offices
Viatris
42 followers
Viatris is a new kind of global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including a global workforce of approximately ~45,000, Viatris aims to deliver increased access to affordable, quality medicines for patients worldwide, regardless of geography or circumstance.